Your browser doesn't support javascript.
loading
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.
Teramoto, Tamio; Kondo, Akira; Kiyosue, Arihiro; Harada-Shiba, Mariko; Ishigaki, Yasushi; Tobita, Kimimasa; Kawabata, Yumiko; Ozaki, Asuka; Baccara-Dinet, Marie T; Sata, Masataka.
Afiliación
  • Teramoto T; Teikyo Academic Research Center, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. ttera@med.teikyo-u.ac.jp.
  • Kondo A; Asia Pacific Development, R&D, Sanofi, Tokyo, Japan.
  • Kiyosue A; Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Harada-Shiba M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
  • Ishigaki Y; Division of Diabetes and Metabolism, Department of Internal Medicine, Iwate Medical University, Iwate, Japan.
  • Tobita K; Asia Pacific Development, R&D, Sanofi, Tokyo, Japan.
  • Kawabata Y; Sanofi Japan, Tokyo, Japan.
  • Ozaki A; Sanofi Japan, Tokyo, Japan.
  • Baccara-Dinet MT; PCSK9 Development and Launch Unit, Sanofi, Montpellier, France.
  • Sata M; Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Lipids Health Dis ; 16(1): 121, 2017 Jun 17.
Article en En | MEDLINE | ID: mdl-28623954

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hipercolesterolemia / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lipids Health Dis Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hipercolesterolemia / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lipids Health Dis Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2017 Tipo del documento: Article País de afiliación: Japón